Abstract Background Glaucoma affects more than 70 million people worldwide, with about 10 being bilaterally blind, making it the leading cause of irreversible blindness globally. In patients with advanced glaucoma or those who have failed medical treatment without achieving adequate intraocular pressure IOP control,